63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details


臨床試験数 : 391 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139

  
6 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR2200058433
2022-04-112022-04-09Belimumab in combination with cyclosporine for corticosteroid-refractory primary immune thrombocytopenia in adultsEfficacy and safety of belliumab in combination with cyclosporine in adults with persistent or chronic corticosteroid-refractory primary immune thrombocytopenia: a single-arm, open, multicenter clinical study Primary immune thrombocytopeniaGroup 1:belimumab and cyclosporine;The Second Affiliated Hospital of Kunming Medical UniversityNULLPendingBothGroup 1:37;China
2ChiCTR2000040991
2022-03-022020-12-16Cyclosporine A combined with eltrombopag in the treatment for primary immune thrombocytopenia: a prospective, multicenter, single-arm, open clinical studyCyclosporine A combined with eltrombopag in the treatment for primary immune thrombocytopenia: a prospective, multicenter, single-arm, open clinical study primary immune thrombocytopeniaexperimental group:Cyclosporine A combined with eltrombopag;The First Affiliated Hospital, College of Medicine, Zhejiang UniversityNULLRecruiting1875Bothexperimental group:28;Phase 4China
3ChiCTR2000030603
2020-05-012020-03-08A multicenter prospective cohort clinical study of a short-course glucocorticoid therapy regimen for glucocorticoid-dependent immune thrombocytopeniaA multicenter prospective cohort clinical study of a short-course glucocorticoid therapy regimen for glucocorticoid-dependent immune thrombocytopenia Primary Immune ThrombocytopeniaThe short -course glucocorticoid group:treat with glucocorticoid;The eltrombopag group:treat with eltrombopag;The rituximab group:treat with rituximab;Splenectomy group:treat with splenectomy;The azathioprine group:treat with azathioprine;The cyclosporine group:treat with cyclosporine;The Second Affiliated Hospital of Kunming Medical UniversityNULLRecruiting1875BothThe short -course glucocorticoid group:65;The eltrombopag group:65;The rituximab group:65;Splenectomy group:65;The azathioprine group:65;The cyclosporine group:65;Phase 4China
4ChiCTR1900027753
2019-12-012019-11-25Efficacy and safety of cyclosporine and azathioprine in patients with refractory ITPEfficacy and safety of cyclosporine and azathioprine in patients with refractory ITP Primary Immune ThrombocytopeniaGroup 1:Using cyclosporine A for treatment;Group 2:Using azathioprine for treatment;Control group:Treatment with glucocorticoids;the Second Affiliated Hospital of Kunming Medical UniversityNULLPending1875BothGroup 1:30;Group 2:30;Control group:30;N/AChina
5ChiCTR-OON-17014165
2018-01-012017-12-27A clinical trial to evaluate the efficacy and safety of corticosteroids combined with cyclosporin A in the treatment of primary immune thrombocytopeniaA clinical trial to evaluate the efficacy and safety of corticosteroids combined with cyclosporin A in the treatment of primary immune thrombocytopenia Immune Thrombocytopeniaone:Corticosteroids;two:Corticosteroids combined with Cyclosporin A ;Tongji Hospital of Tongji Medical College, Huazhong University of Science and TechnologyNULLRecruiting1865Bothone:100;two:100;China
6NCT01437384
(ClinicalTrials.gov)
September 201119/9/2011Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects Comparing the Interactions Between E5501 and Verapamil and Cyclosporine.An Open-label, Single-sequence, Four-treatment Period Study to Evaluate Pharmacokinetic and Pharmacodynamic Interactions Between E5501 and Verapamil, and E5501 and Cyclosporine, Known P-glycoprotein Inhibitors in Healthy SubjectsIdiopathic Thrombocytopenic Purpura (ITP)Drug: E5501Eisai Inc.NULLCompleted18 Years55 YearsBoth36Phase 1United States